Shepherd, Finkelman, Miller & Shah, LLP (“SFMS”) announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York (Civil Action No. 17-01233) against Alcobra, Ltd. (“Alcobra”)(ADHD) and certain of its officers and directors. The case seeks remedies under the Securities Exchange Act of 1934 …
Pomerantz LLP announces that a class action lawsuit has been filed against TG Therapeutics, Inc. (“TG Therapeutics” or the “Company”) (NASDAQ: TGTX ) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-00508, is on behalf of a class consisting of all persons or …
The complaint alleges that on September 8, 2014 , Seres announced final data from its Phase 1b clinical trial of SER-109, which yielded positive results including clinical cures and a favorable safety profile. Seres proceeded to Phase 2 of the clinical trial to further evaluate the efficacy of SER-109. Meanwhile, the company shed SER-109 in a positive light, stating that it believed SER-109 …